All trans retinoic acid abrogates spontaneous monocytic growth in juvenile chronic myelomonocytic leukaemia

Hematology Journal

Volumn 2, Issue 2, 2001, Pages 97-102

  Cambier, N ^a   Menot, M L ^a   Schlageter, M H ^a   Balitrand, N ^a   Leblanc, T ^a   Bordigoni, P ^a   Rohrlich, P ^a   Lamagnere J P ^a   Donadieu, J ^a   Herbelin, C ^a   Puissant, C ^a   Gourand, F ^a   Baruchel, A ^a   Chomienne, C ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

JCML; JMML; Retinoic acid

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; METHYLCELLULOSE; RETINOIC ACID; RETINOID;

ARTICLE; ASSAY; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL SUSPENSION; CHILD; CHILDHOOD LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; COLONY FORMING UNIT C; COLONY FORMING UNIT GM; COLONY FORMING UNIT M; CONTROLLED STUDY; CULTURE MEDIUM; GRANULOCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; INHIBITION KINETICS; LEUKOCYTE; MONOCYTE; MONONUCLEAR CELL; PROMYELOCYTE;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; FEMALE; GRANULOCYTE PRECURSOR CELLS; HUMANS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0035011078     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200099     Document Type: Article

References (48)

1. Retinoids in cancer prevention and therapy
2. All-trans retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia
3. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid)
4. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid
5. All-trans retinoic acid in acute promyelocytic leukemias II. In vitro studies: Structure and relationship
6. Differential expression of gene encoding retinoic acid receptors and CRABPs in human haematopoietic cells: Involvement of RARα and CRABPII in the RA-retinoic acid treatment of acute promyelocytic leukemia
7. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocytic stage
8. The PML-RARα gene product of the t(15;17) translocation inhibits retinoic acid induced granulocytic differentiation
9. The acute promyelocytic leukemia-specific PML-RARα inhibits differentiation and promotes survival of myeloid precursor cells
10. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus
11. PLZF-RAR fusion protein generated from the trarislocation t(11;17)(q23;q21) displays altered transactivation properties against the wild-type retinoic acid receptors
12. Retinoic acid enhances colony-stimulating factor induced clonal growth of normal human myeloid progenitor cells in vitro
13. Retinoic acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells
14. Direct effects of 13 cis and all-trans RA on normal Bone Marrow (BM) progenitors: Comparative study on BM mononuclear cells and on isolated CD34+ BM cells
15. 9-cis retinoic acid effects on normal and leukemic hematopoiesis in vitro
16. Effect of RA on myeloid progenitors in normal bone marrow
17. Inhibition of normal human macrophage progenitors by retinoic acid
18. Juvenile chronic myelogenous leukemia
19. Juvenile 'chronic granulocytic' leukemia: A panmyelopathy with prominent monocytic involvement and circulating monocyte colony-forming cells
20. Central role of tumour necrosis factor, GM-CSF and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukemia
21. Juvenile chronic myelogenous leukemia: Characterization of the disease using cell cultures
22. Characterization of hematopoietic cells in juvenile-type chronic myelocytic leukemia
23. Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation, in juvenile chronic myelogenous leukemia
24. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders
25. Monosomy 7 syndrome in an infant with neurofibromatosis
26. Treatment of Juvenile Chronic Myelomonocytic Leukemia by allogeneic bone marrow transplantation
27. In vivo 13-cis retinoic acid therapy decreases the in vitro GM-CSF hypersensitivity in Juvenile Chronic Myelogenous Leukemia
28. A pilot sudy of isotretinoin in the treatment of Juvenile Chronic Myelogenous Leukemia
29. Cell culture studies and oncogene expression in juvenile chronic myelogeneous leukemia
30. RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders and myelodysplastic syndromes
31. Fusion of PDGFa receptor to a novel ets like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
32. Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children
33. EVI-1 gene expression in myeloid clonogenic cells from juvenile myelomonocytic leukemia (JCMML)
34. Cloning and sequencing of an alternative splicing-derived cDNA variant of the GM-CSF receptor alpha subunit, which encodes a truncated protein
35. Analysis of the coding sequence for the GM-CSF receptor alpha and beta chains in patients with juvenile chronic myeloid leukemia (JCML)
36. Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice
37. Induction treatment of acute promyelocytic leukemia using all-trans retinoic acid. Controversies about dosage, advantages and side-effect management
38. Suppression of juvenile chronic myelogenous leukemia colony growth by interleukin-1 receptor antagonist
39. Recombinant human interferon alpha-2 and juvenile chronic myelogenous leukemia: Cell receptor binding, enzymatic induction, and growth suppression in vitro
40. Interleukin 4 supresses the spontaneous growth of chronic myelomonocytic leukemia cells
41. Genomic sequence for human pro-interleukin 1 alpha gene
42. Retinoic acid potentiate IL-Ib and FGF induced synovial fibroblast proliferation
43. Induction of human interleukin-1 gene expression by retinoic acid and its regulation at processing of precursor transcripts
44. Modulation of II-6 and II-1α and G-CSF secretion by all trans retinoic acid in Acute Promyelocytic leukemia
45. Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient mice
46. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia
47. All-trans retinoic acid pharmacokinetics and bioavailability in acute promyelocytic leukemia: Intracellular concentrations and biologic response relationship